Koers Kun Run Biotechnology, Inc.

Aandelen

17-06-10	KUN RUN BIOTCH : Kun Run Biotechnology Announces That They Have Obtained the Manufacturing Approval for Entecavir from the China State Food and Drug Administration
22-04-10	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Executes Purchase Agreements for Approximately $8 Million Private Placement
30-03-10	KUN RUN BIOTCH : Kun Run Biotechnology Reports Fourth Quarter and Fiscal Year 2009 Financial Results
13-11-09	KUN RUN BIOTCH : Kun Run Biotechnology, Inc. Announces Third Quarter 2009 Results
30-11--1	KUN RUN BIOTECHNLG : Kun Run Biotechnology, Inc. Year-End Revenues Increase 56% to $11.6 million

Toevoegen aan een lijst 0 geselecteerde Om deze functie te gebruiken moet u een klant of lid zijn. Inloggen Registreren	Verschil (%)	Varia. 5d.	Varia. 1j.	Varia. 3j.	Kap.($)
KUN RUN BIOTECHNOLOGY, INC.	-.--%	-.--%	-	-	0
SUN PHARMACEUTICAL INDUSTRIES LTD.	-0,08%	-1,43%	+15,99%	+67,26%	47,71 mld.
OTSUKA HOLDINGS CO., LTD.	-3,21%	+1,37%	+52,36%	+125,75%	40,3 mld.
CIPLA LIMITED	-0,40%	-1,23%	-10,08%	+16,08%	12,09 mld.
ZYDUS LIFESCIENCES LIMITED	+1,11%	-1,34%	+13,61%	+71,49%	11,68 mld.
KRKA, D. D.	0,00%	+0,58%	+30,65%	+148,80%	9,19 mld.
GEDEON RICHTER	-0,39%	-0,92%	+19,81%	+39,54%	7,57 mld.
ONO PHARMACEUTICAL CO., LTD.	-1,35%	+0,74%	+47,03%	-11,93%	7,24 mld.
GLENMARK PHARMACEUTICALS LIMITED	-0,64%	-0,02%	+19,42%	+199,06%	6,84 mld.
SHENZHEN SALUBRIS PHARMACEUTICALS CO., LTD.	-5,36%	-6,36%	-36,28%	+18,28%	5,42 mld.
Gemiddelde	-1,03%	-1,11%	+16,95%	+74,93%	16,45 mld.
Gewogen gemiddelde per kap.	-1,16%	-0,57%	+24,44%	+83,40%